Innovation in research on micro- and nanoplastics and their effects on human health
We are a multidisciplinary team with expertise in a wide range of fields including food sciences & technology, allergy, immunology, biomedicine, biology, chemistry, bioinformatics, machine learning, paediatrics and others, cooperating across Europe to investigate the relationship among micro- and nanoplastics (MNPs) and allergic diseases.
The Project
Untangling the multifaceted relationship of exposure routes, risks and health impacts of MNPs.
Improving MNP detection
We plan to develop innovative tools to measure and characterize MNPs and potential contaminants in food, water and air.
MNPs combined with pollutants
We are committed to understanding the effect of MNPs combined with potentially harmful environmental contaminants adhering to their surfaces and finding their way into the human body.
The relationship with allergic diseases
We aim to examine a possible link between MNPs and their role in food allergy and allergic asthma.
Highlights
Are Microplastics Fuelling the Allergy Epidemic? Key Insights from the Imptox Stakeholder Dialogue
Scientists, policymakers, and patient advocates met in Brussels to explore a possible new player in allergic disease - tiny plastic particles hiding in our food, air, and bodies.
Impact of Micro- and Nanoplastic Particles on Allergies: New Insights
At the recent Imptox Stakeholder Dialogue in Brussels, Imptox Scientist, Dr. Michelle Epstein from the Medical University of Vienna presented groundbreaking research exploring the effects of micro- and nanoplastic particles (MNPs) on allergic diseases.
JOIN our Stakeholder Dialogue: Plastic Particles, Allergies, and Emerging Risks
Imptox researchers explore the link between plastic particles and allergic disease at a hybrid event for stakeholders in Brussels.
The Unintended Consequences of Innovation – From Plastics to the Microplastics Crisis
Prof. Dr. Ulrike Felt from the University of Vienna explains how a revolutionary material became an environmental challenge and what it teaches us about responsible innovation.
The Imptox Team
Imptox is a multidisciplinary consortium of 12 partners from 8 European countries.
